The FDA has warned COVID-19 serological test-makers not to overstate the usefulness – or claim federal approval – of their products, cautioning that it may still be too early for such diagnostics to be meaningful. Unlike more widespread test processes, which look for the coronavirus itself in samples taken from patients, serological tests instead look for the body’s immune response …
The FDA has warned COVID-19 serological test-makers not to overstate the usefulness – or claim federal approval – of their products, cautioning that it may still be too early for such diagnostics to be meaningful. Unlike more widespread test processes, which look for the coronavirus itself in samples taken from patients, serological tests instead look for the body’s immune response …
Share this Article
Recommended